| __timestamp | Merck & Co., Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7180000000 | 7459000 |
| Thursday, January 1, 2015 | 6704000000 | 11831000 |
| Friday, January 1, 2016 | 7194000000 | 25705000 |
| Sunday, January 1, 2017 | 9982000000 | 46181000 |
| Monday, January 1, 2018 | 9752000000 | 59497000 |
| Tuesday, January 1, 2019 | 9872000000 | 65003000 |
| Wednesday, January 1, 2020 | 13397000000 | 74506000 |
| Friday, January 1, 2021 | 12245000000 | 126006000 |
| Saturday, January 1, 2022 | 13548000000 | 126215000 |
| Sunday, January 1, 2023 | 30531000000 | 120161000 |
Data in motion
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Merck & Co., Inc. has consistently outpaced Protagonist Therapeutics, Inc. in research and development (R&D) spending. From 2014 to 2023, Merck's R&D expenses surged by over 300%, peaking at $30.5 billion in 2023. In contrast, Protagonist's investment grew modestly, reaching $126 million in the same year. This stark difference highlights Merck's commitment to innovation, investing nearly 250 times more than Protagonist in 2023 alone. Such substantial investment positions Merck as a leader in pharmaceutical advancements, while Protagonist, with its more focused approach, may be targeting niche innovations. As the industry evolves, these investment strategies will shape the future of healthcare breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Insmed Incorporated
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Opthea Limited
Analyzing R&D Budgets: Merck & Co., Inc. vs Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
R&D Insights: How Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Dynavax Technologies Corporation
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
Sanofi vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Protagonist Therapeutics, Inc. vs MiMedx Group, Inc.: Strategic Focus on R&D Spending